New Weight-Loss Drugs Are Sending a Surprising Number of Americans to the Emergency Room

In the active ingredient of popular medications, the active ingredient of popular drugs is ozempic and wegovy, not risk-free. Recent study found that in the last few years, the emergency room ended from the adoption of the semaglutitide of ten thousands of Americans.

Scientists from the centers of disease control and prevention were investigated, published This month in the annal of internal medicine. According to national control information, researchers assess that the semaglutid has contributed about 2022 to 2023, generally contributed to about 25,000 ER visits. Findings show that doctors can do more to reduce potential severe side effects of these drugs.

One of the few hormones that are one of several hormones playing a key role in adjusting our metabolism, metabolism and our hunger. GLP-1 drugs are more than two decades, but the semaglutide is a newer and more effective generation. First, in 2017, the Type 2 Diabetes was approved to treat the brand Adempic. In 2021, it was approved to treat the fat under the wegovy brand. Since then, doctors have also designated the ozempic off-label to lose weight.

Every drug comes with side effects. People who receive GLP-1S usually live in the heartbreak, diarrhea and other GI symptoms. Usually, this side effects inclined to decrease in light and / or time. However, in some cases, they can be serious as it can guarantee emergency medical services.

CDC researchers analyzed information from National Electronic Injury System-Cooperative Negative Drug Details (Neiss-cades), following drug-related adverse events, was reported to an example of the National Representation of Emergency Departments in the United States

According to the 551 documentary, researchers estimated that 24,499 Armenian visit belongs to the use of semaglutide between 2022 and 2023. 70% of these visits are represented by allergic reactions about 17% hypoglycemia (low blood sugar) and about 6% of allergies. One-third of the trips related to hypoglycemia, 15% of visits related to 8% caused hospitalization.

The findings should be taken in some context. Many drugs, including general extreme drugs, can also cause side effects that may include. In 2021 they saw that many of the same authors examined In about 200 Americans 1 For example, because of the causes of therapeutic use, drug-related losses and two-thirds for drugs (because drugs are accepted for taking medical problems). 2022 research by the same team estimated OTC cough or cold medications cause about 27,000 ER visits each year.

However, the results of this recent study should not be minimized. In 2023, more than 82% of the Armenian trips, because it is the use of semaglutide, it shows that there are potential losses. Approximately 9%, medicinal mistakes as people who receive more than instructions. Thus, we will be able to prevent some ER visits with better patient education. In other cases, doctors can reduce the risk of serious complications by better management of other drugs and at least, they can probably do more to prepare patients before researchers.

“Clinicians can advise patients to patients for severe gastrointestinal adverse effects and adjust the antidiabetic drugs regulating antidiabetic drugs to reduce the risk of hypoglycemia,” the authors wrote.